Published in Nature on May 25, 2011
Global control of hepatitis C: where challenge meets opportunity. Nat Med (2013) 2.22
The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis. PLoS One (2014) 1.58
Underascertainment of acute hepatitis C virus infections in the U.S. surveillance system: a case series and chart review. Ann Intern Med (2015) 1.48
Toward a more accurate estimate of the prevalence of hepatitis C in the United States. Hepatology (2015) 1.44
Hepatitis C screening: getting it right. Hepatology (2012) 0.94
Barriers of hepatitis C virus interspecies transmission. Virology (2013) 0.92
Lower liver-related death in African-American women with human immunodeficiency virus/hepatitis C virus coinfection, compared to Caucasian and Hispanic women. Hepatology (2012) 0.91
Identification and analysis of inhibitors targeting the hepatitis C virus NS3 helicase. Methods Enzymol (2012) 0.91
Murine models of hepatitis C: what can we look forward to? Antiviral Res (2014) 0.90
Discovering new medicines targeting helicases: challenges and recent progress. J Biomol Screen (2013) 0.85
Estimating HCV prevalence at the state level: a call to increase and strengthen current surveillance systems. Am J Public Health (2013) 0.85
Quantitative proteomic analysis in HCV-induced HCC reveals sets of proteins with potential significance for racial disparity. J Transl Med (2013) 0.81
Studying the immune response to human viral infections using zebrafish. Dev Comp Immunol (2014) 0.80
Natural Products as Tools for Defining How Cellular Metabolism Influences Cellular Immune and Inflammatory Function during Chronic Infection. Viruses (2015) 0.79
Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland. PLoS One (2015) 0.79
Prevalence and correlates of hepatitis C virus infection among inmates at two New York State correctional facilities. J Infect Public Health (2014) 0.79
Racial/ethnic differences in spontaneous HCV clearance in HIV infected and uninfected women. Dig Dis Sci (2012) 0.79
Prospects for prophylactic hepatitis C vaccines based on virus-like particles. Hum Vaccin Immunother (2013) 0.78
Surveillance system for hepatitis C infection: A practical approach. Int J Prev Med (2012) 0.77
Estimating the true prevalence of hepatitis C in rhode island. R I Med J (2013) (2014) 0.77
State of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and Immunization. J Immunol Res (2016) 0.75
Direct-acting antiviral agents in patients with hepatitis C cirrhosis. Gastroenterol Hepatol (N Y) (2012) 0.75
Correlates of Hepatitis C Virus Infection in the Targeted Testing Program of the New York City Jail System. Public Health Rep (2016) 0.75
Spillover effects of HIV testing policies: changes in HIV testing guidelines and HCV testing practices in drug treatment programs in the United States. BMC Public Health (2016) 0.75
Status of hepatitis C virus vaccination: Recent update. World J Gastroenterol (2016) 0.75
Ending the mass criminalisation of people who use drugs: a necessary component of the public health response to hepatitis C. BMC Infect Dis (2014) 0.75
Genomic variants link to hepatitis C racial disparities. Oncotarget (2017) 0.75